Whole genomic comparative analysis of Streptococcus pneumoniae serotype 1 isolates causing invasive and non-invasive infections among children under 5 years in Casablanca, Morocco.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
07 Jan 2021
Historique:
received: 19 07 2020
accepted: 09 12 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Streptococcus pneumoniae serotype 1 remains a leading cause of invasive pneumococcal diseases, even in countries with PCV-10/PCV-13 vaccine implementation. The main objective of this study, which is part of the Pneumococcal African Genome project (PAGe), was to determine the phylogenetic relationships of serotype 1 isolates recovered from children patients in Casablanca (Morocco), compared to these from other African countries; and to investigate the contribution of accessory genes and recombination events to the genetic diversity of this serotype. The genome average size of the six-pneumococcus serotype 1 from Casablanca was 2,227,119 bp, and the average content of coding sequences was 2113, ranging from 2041 to 2161. Pangenome analysis of the 80 genomes used in this study revealed 1685 core genes and 1805 accessory genes. The phylogenetic tree based on core genes and the hierarchical bayesian clustering analysis revealed five sublineages with a phylogeographic structure by country. The Moroccan strains cluster in two different lineages, the five invasive strains clusters altogether in a divergent clade distantly related to the non-invasive strain, that cluster with all the serotype 1 genomes from Africa. The whole genome sequencing provides increased resolution analysis of the highly virulent serotype 1 in Casablanca, Morocco. Our results are concordant with previous works, showing that the phylogeography of S. pneumoniae serotype 1 is structured by country, and despite the small size (six isolates) of the Moroccan sample, our analysis shows the genetic cohesion of the Moroccan invasive isolates.

Sections du résumé

BACKGROUND BACKGROUND
Streptococcus pneumoniae serotype 1 remains a leading cause of invasive pneumococcal diseases, even in countries with PCV-10/PCV-13 vaccine implementation. The main objective of this study, which is part of the Pneumococcal African Genome project (PAGe), was to determine the phylogenetic relationships of serotype 1 isolates recovered from children patients in Casablanca (Morocco), compared to these from other African countries; and to investigate the contribution of accessory genes and recombination events to the genetic diversity of this serotype.
RESULTS RESULTS
The genome average size of the six-pneumococcus serotype 1 from Casablanca was 2,227,119 bp, and the average content of coding sequences was 2113, ranging from 2041 to 2161. Pangenome analysis of the 80 genomes used in this study revealed 1685 core genes and 1805 accessory genes. The phylogenetic tree based on core genes and the hierarchical bayesian clustering analysis revealed five sublineages with a phylogeographic structure by country. The Moroccan strains cluster in two different lineages, the five invasive strains clusters altogether in a divergent clade distantly related to the non-invasive strain, that cluster with all the serotype 1 genomes from Africa.
CONCLUSIONS CONCLUSIONS
The whole genome sequencing provides increased resolution analysis of the highly virulent serotype 1 in Casablanca, Morocco. Our results are concordant with previous works, showing that the phylogeography of S. pneumoniae serotype 1 is structured by country, and despite the small size (six isolates) of the Moroccan sample, our analysis shows the genetic cohesion of the Moroccan invasive isolates.

Identifiants

pubmed: 33413118
doi: 10.1186/s12864-020-07316-0
pii: 10.1186/s12864-020-07316-0
pmc: PMC7792055
doi:

Substances chimiques

Pneumococcal Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39

Subventions

Organisme : Medical Research Council
ID : MR/R003076/1
Pays : United Kingdom
Organisme : Bill and Melinda Gates Foundation
ID : OPP1023440

Références

J Clin Microbiol. 2018 Apr 25;56(5):
pubmed: 29444837
BMC Genomics. 2012 Oct 29;13:569
pubmed: 23107513
F1000Prime Rep. 2014 Sep 04;6:82
pubmed: 25343039
Bioinformatics. 2009 Aug 1;25(15):1972-3
pubmed: 19505945
Genome Biol. 2010;11(10):R107
pubmed: 21034474
Bioinform Biol Insights. 2020 Sep 29;14:1177932220962106
pubmed: 33088176
J Infect Dis. 2009 Apr 1;199(7):1032-42
pubmed: 19203261
J Biomed Sci. 2018 Feb 15;25(1):15
pubmed: 29448938
PLoS One. 2014 Aug 08;9(8):e103625
pubmed: 25105894
Clin Microbiol Rev. 2015 Jul;28(3):871-99
pubmed: 26085553
J Clin Microbiol. 2016 May;54(5):1326-34
pubmed: 26962082
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
F1000Res. 2013 Mar 01;2:67
pubmed: 24358875
PLoS One. 2010 Jun 25;5(6):e11147
pubmed: 20593022
Microb Genom. 2015 Aug 11;1(2):e000027
pubmed: 28348812
Sci Rep. 2018 Dec 19;8(1):17959
pubmed: 30568178
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Front Microbiol. 2018 Oct 30;9:2580
pubmed: 30425695
PLoS Med. 2010 Oct 05;7(10):
pubmed: 20957191
Comput Struct Biotechnol J. 2015 Apr 08;13:241-7
pubmed: 25904996
Infect Genet Evol. 2015 Jul;33:371-80
pubmed: 25445643
J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii20-vii31
pubmed: 29982573
Infect Drug Resist. 2018 May 03;11:659-670
pubmed: 29765237
PLoS One. 2012;7(10):e26742
pubmed: 23082106
BMC Infect Dis. 2016 Oct 18;16(1):575
pubmed: 27756235
BMC Infect Dis. 2016 Nov 8;16(1):649
pubmed: 27821148
BMC Genet. 2010 Oct 15;11:94
pubmed: 20950446
Bioinformatics. 2010 Feb 1;26(3):419-20
pubmed: 20080509
Expert Rev Vaccines. 2018 Jun;17(6):479-493
pubmed: 29241390
Vaccine. 2017 Aug 16;35(35 Pt B):4594-4602
pubmed: 28711389
Lancet. 2019 May 25;393(10186):2146-2154
pubmed: 31000194
PLoS One. 2017 May 22;12(5):e0178040
pubmed: 28531208
Clin Infect Dis. 2000 Feb;30(2):319-21
pubmed: 10671335
Int J Infect Dis. 2015 Nov;40:95-101
pubmed: 26434380
Nat Genet. 2014 Mar;46(3):305-309
pubmed: 24509479
Nat Genet. 2013 Jun;45(6):656-63
pubmed: 23644493
Pediatr Infect Dis J. 2015 Nov;34(11):1168-74
pubmed: 26226445
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
mBio. 2016 Sep 27;7(5):
pubmed: 27677790
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349

Auteurs

Néhémie Nzoyikorera (N)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco. nzoyikorera@yahoo.fr.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco. nzoyikorera@yahoo.fr.

Idrissa Diawara (I)

Faculty of Sciences and Health Techniques, Mohammed VI University of Health Sciences (UM6SS) of Casablanca, Casablanca, Morocco.

Pablo Fresia (P)

Institut Pasteur de Montevideo, Pasteur + INIA Joint Unit (UMPI), Montevideo, Uruguay.
Institut Pasteur de Montevideo, Microbial Genomics Laboratory, Montevideo, Uruguay.

Fakhreddine Maaloum (F)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco.

Khalid Katfy (K)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco.

Kaotar Nayme (K)

Molecular Bacteriology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.

Mossaab Maaloum (M)

Laboratory of Biology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca, Morocco.
Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.

Jennifer Cornick (J)

Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.

Chrispin Chaguza (C)

Wellcome Trust Sanger Institute, Cambridge, UK.

Mohammed Timinouni (M)

Molecular Bacteriology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.

Houria Belabess (H)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco.

Khalid Zerouali (K)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco.

Naima Elmdaghri (N)

Department of Microbiology, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca, Casablanca, Morocco.
Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca, Morocco.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH